HCA earnings

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): Revenues increased 4.3 percent to $19.109 billion Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9 percent to $7.15 per diluted share Adjusted EBITDA increased 1.9 percent to $3.802 billion Cash flows from operating activities increased 22.0 percent to $2.014 billion Same facility admissions increased 0.9 percent and same fac

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2026 Earnings Call When: Friday, April 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20260326232305/en/ INVESTOR CONTACT: Frank Morg

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion Diluted earnings per share increased 44.6 percent to $8.14 per share, and diluted earnings per share, as adjusted, increased 28.8 percent to $8.01 per share Adjusted EBITDA increased 10.8 percent to $4.114 billion Cash flows from operating activities totaled $2.359 billion, compared to $2.559 billion in the fou

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What:   HCA Healthcare, Inc. 4Q 2025 Earnings Call When:   Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How:   Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://

Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share Adjusted EBITDA increased 18.5 percent to $3.870 billion Cash flows from operating activities totaled $4.416 billion,

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2025 Earnings Call When: Friday, October 24, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news

Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): Revenues increased 6.4 percent to $18.605 billion Net income attributable to HCA Healthcare, Inc. increased 13.1 percent to $1.653 billion Diluted earnings per share increased 23.5 percent to $6.83 per diluted share, and diluted earnings per share, as adjusted, increased 24.4 percent to $6.84 per diluted share Adjusted EBITDA increased 8.4 percent to $3.849 billion Cash flows from operating activities totaled $4.210 billion, com

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2025 Earnings Call When: Friday, July 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20250404757460/en/ INVESTOR CONTACT: Frank Morgan

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton) Adjusted EBITDA totaled $3.712 billion Cash flows from operating activities totaled $2.559 billion Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent "

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast:   What: HCA Healthcare, Inc. 4Q 2024 Earnings Call   When: Friday, January 24, 2025 at 9:00 AM Central (10:00 AM Eastern)   How: Live Audio over the Internet:     https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 25, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20240926343840

Raises 2024 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share Adjusted EBITDA totaled $3.550 billion Cash flows from operating activities totaled $1.971 billion Same facility admissions increased 5.8 percent while same facility equivalent admissions increased 5.2 percent "The company's results for the second quarter were positive and reflected strong demand

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/hom

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): Revenues totaled $17.339 billion Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share Adjusted EBITDA totaled $3.353 billion Cash flows from operating activities totaled $2.469 billion Same facility admissions increased 6.2 percent while same facility equivalent admissions increased 5.2 percent "The strong fundamentals we saw in our business this past year continued into the first quarter of 2024. This m

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q Earnings Release Call When: Friday, April 26, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.co

Bill Rutherford to Retire and Mike Marks to Become CFO HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2023. Key fourth quarter metrics (all percentage changes compare 4Q 2023 to 4Q 2022 unless otherwise noted): Revenues totaled $17.303 billion Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share Adjusted EBITDA totaled $3.618 billion Cash flows from operating activities totaled $2.674 billion Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent "In the quarter, we experienced strong demand for

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q Earnings Release Call When: Tuesday, January 30, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news

Revises 2023 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): Revenues totaled $16.213 billion Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share Adjusted EBITDA totaled $2.880 billion Cash flows from operating activities totaled $2.479 billion Same facility admissions increased 3.4 percent while same facility equivalent admissions increased 4.1 percent "During the quarter, most aspects of our business were positive, including continue

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com

Raises 2023 Guidance HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the second quarter ended June 30, 2023. Key second quarter metrics (all percentage changes compare 2Q 2023 to 2Q 2022 unless otherwise noted): Revenues totaled $15.861 billion Net income attributable to HCA Healthcare, Inc. totaled $1.193 billion, or $4.29 per diluted share Adjusted EBITDA totaled $3.056 billion Cash flows from operating activities totaled $2.475 billion Same facility admissions increased 2.2 percent and same facility equivalent admissions increased 3.7 percent "The company produced solid results in the second quarter driven by continued strong dem

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Thursday, July 27, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/202

Revises 2023 Guidance HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the first quarter ended March 31, 2023. Key first quarter metrics (all percentage changes compare 1Q 2023 to 1Q 2022 unless otherwise noted): Revenues totaled $15.591 billion Net income attributable to HCA Healthcare, Inc. totaled $1.363 billion, or $4.85 per diluted share Adjusted EBITDA totaled $3.172 billion Cash flows from operating activities totaled $1.803 billion Same facility admissions increased 4.4 percent and same facility equivalent admissions increased 7.5 percent "Once again this quarter, our colleagues demonstrated a remarkable ability to adapt and

Company raises $12 million of new equity from HCA Healthcare and Redmile Group;Augmedix and HCA Healthcare to collaborate on AI-powered ambient documentation products for the acute care setting;Provides sufficient capital to achieve cash flow sustainability SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that it has executed a strategic financing with HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, and Redmile Group, LLC, a San

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q Earnings Release Call When: Friday, April 21, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20230328005239/en/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2022. Key fourth quarter metrics (all percentage changes compare 4Q 2022 to 4Q 2021 unless otherwise noted): Revenues totaled $15.497 billion Net income attributable to HCA Healthcare, Inc. totaled $2.081 billion, or $7.28 per diluted share Adjusted EBITDA totaled $3.179 billion Cash flows from operating activities totaled $2.527 billion Same facility admissions increased 2.9 percent while same facility equivalent admissions increased 5.4 percent "The last three years have been an extraordinary experience for everyone at HCA Healthcare. It was truly a challe

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q Earnings Release Call When: Friday, January 27, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005780/en/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2022. Key third quarter metrics (all percentage changes compare 3Q 2022 to 3Q 2021 unless otherwise noted): Revenues totaled $14.971 billion Net income attributable to HCA Healthcare, Inc. totaled $1.134 billion, or $3.91 per diluted share Adjusted EBITDA totaled $2.902 billion Cash flows from operating activities totaled $3.020 billion Same facility admissions declined 1.5 percent while same facility equivalent admissions increased 2.3 percent "Despite a difficult comparison to the prior year due to the COVID-19 Delta variant, we are pleased with our result

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 21, 2022 at 8:00 am central (9:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20220929005756/en/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2022. Key second quarter metrics (all percentage changes compare 2Q 2022 to 2Q 2021 unless otherwise noted): Revenues totaled $14.820 billion Net income attributable to HCA Healthcare, Inc. totaled $1.155 billion, or $3.90 per diluted share Adjusted EBITDA totaled $3.042 billion Cash flows from operating activities totaled $1.630 billion Same facility admissions declined 1.2 percent and same facility equivalent admissions increased 0.5 percent "Many aspects of our business were positive considering the challenges we faced with the labor market and other inflatio

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Friday, July 22, 2022 at 8:00 am central (9:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20220707005187/en/

Revises 2022 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2022. Key first quarter metrics (all percentage changes compare 1Q 2022 to 1Q 2021 unless otherwise noted): Revenues totaled $14.945 billion Net income attributable to HCA Healthcare, Inc. totaled $1.273 billion, or $4.14 per diluted share Adjusted EBITDA totaled $2.944 billion Cash flows from operating activities totaled $1.345 billion Same facility admissions increased 2.1 percent and same facility equivalent admissions increased 5.0 percent "As always, our colleagues and physicians continued to show-up and deliver on our promise to prov

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q Earnings Release Call When: Friday, April 22, 2022 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20220407005226/en/

Company Increases Capital Spending, Authorizes Additional Share Repurchase Program and Increases Quarterly Dividend HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2021. Key fourth quarter metrics (all percentage changes compare 4Q 2021 to 4Q 2020 unless otherwise noted): Revenues totaled $15.064 billion Net income attributable to HCA Healthcare, Inc. totaled $1.814 billion, or $5.75 per diluted share Adjusted EBITDA totaled $3.149 billion Cash flows provided by operating activities totaled $2.443 billion Same facility admissions and same facility equivalent admissions increased 0.6 percent and 4.1 percent

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q Earnings Release Call When: Thursday, January 27, 2022 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005958/en/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2021. Key third quarter metrics (all percentage changes compare 3Q 2021 to 3Q 2020 unless otherwise noted): Revenues totaled $15.276 billion Net income attributable to HCA Healthcare, Inc. totaled $2.269 billion, or $7.00 per diluted share Adjusted EBITDA totaled $3.224 billion Cash flows from operating activities totaled $2.277 billion Same facility admissions and same facility equivalent admissions increased 6.8 percent and 9.3 percent, respectively "During the third quarter we experienced the most intense surge yet of the pandemic, and our colleagues and

HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 22, 2021 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005778/en/

HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2021. Key second quarter metrics (all percentage changes compare 2Q 2021 to 2Q 2020 unless otherwise noted): Revenues totaled $14.435 billion Net income attributable to HCA Healthcare, Inc. totaled $1.450 billion, or $4.36 per diluted share Adjusted EBITDA totaled $3.219 billion Cash flows from operating activities totaled $2.251 billion Same facility admissions increased 17.5 percent and same facility equivalent admissions increased 26.8 percent "With the effects of the pandemic moderating in the second quarter, we experienced a strong rebound in demand for hea

PALM BEACH,  Fla., Dec. 1, 2020 /PRNewswire/ -- In times of turmoil many small companies struggle to survive and this pandemic has launched M&A across many industries… healthcare is one of them. Sometimes small companies initially may try to maintain their independence but, eventually they see that maybe the best thing for their patients is to become part of a larger whole. Providers have been consolidating over the last decade as organizations pursue economies of scale and expand vertically and horizontally. Post–Covid-19, it is expected that larger healthcare groups and investors will accelerate their acquisitions of smaller hospitals, physician practices and alternative sites of care.